B-cell memory has been extensively analyzed in the systemic immune response elicited by hapten-carrier antigens, and the regulatory mechanisms underlying the process are beginning to be elucidated. Memory B cells can be generated through heterogeneous pathways within and outside germinal centers (GCs). Once developed, they appear to be maintained like stem cells for long periods by homeostatic proliferation. In response to reencountered antigens, memory B cells robustly secrete antibodies with help of the anti-apoptotic effect of Rasmediated signals. We have recently found that following intranasal infection with an influenza virus, virusspecific memory B cells develop in the lungs and persist for a long time along with GC B cells and plasma cells; this appears to be unique feature of the mucosal memory response. Thus memory B cell responses in the systemic and mucosal sites are regulated by distinct processes and further understanding of them should provide a theoretical framework for the development of new vaccine strategies.
A hallmark of the adaptive immune response is memorization of an encounter with a pathogen for several decades. The phenomenon called ''immunological memory,'' by which a primed host can promptly and vigorously eliminate invading pathogens, is the basis of the protective immunity provided by vaccinations or previous infections. 1) During an acute infection with live pathogens, including influenza viruses, immunological memory can be established in the cellular (cytotoxic T cell) and humoral (neutralizing antibody) immune responses. Antigenic epitopes for cytotoxic T cells are generally less variable than those for neutralizing antibodies among the different subtypes of influenza viruses. Thus influenza vaccines targeting cytotoxic T cells can confer cross-protection across the different subtypes of viruses, but blockade of cellular immunity by removal of CD8 þ T cells does not abolish viral clearance, 2) and antibodies against viral surface glycoprotein hemagglutinin (HA) on their own are able to eliminate the virus. 3) Hence it is generally accepted that vaccine-induced neutralizing antibodies offer the best protection against influenza viruses, while cytotoxic T cells can reduce the severity of infection by lowering the spread of viruses. 4) This is also supported by the fact that all the successful vaccines that provide long-lasting protective immunity are largely dependent on neutralizing antibodies. 5) Two types of long-lived B cell subsets are responsible for humoral memory response, long-lived plasma cells and memory B cells. 6) Both of these cell types are longlived and express high-affinity B-cell antigen receptor (BCR). Memory B cells promptly secrete large amounts of antibodies upon re-infection with a pathogen, while long-lived plasma cells continuously secrete antibodies to maintain a minimum level of protective antibodies long after the first infection. Thus these long-lived B cells neutralize the re-invading pathogens in two steps. Protective high-affinity antibodies from long-lived plasma cells bind to the pathogen immediately after infection, and the following robust secretion of highaffinity antibodies from re-stimulated memory B cells completely eliminates the residual pathogen.
Memory B cells are different from naive B cells in three ways: (i) they express isotype-switched, highaffitniy antibodies; (ii) they are long-lived; and (iii) they promptly produce large amounts of antibodies in response to antigenic stimulation. [7] [8] [9] [10] [11] In the first three sections of this review, I will discuss the molecular basis of distinct properties of memory B cells and long-lived plasma cells based on an analysis of systemic memory response against a hapten-carrier antigen. In the final section, I will discuss a unique feature of the mucosal memory B cell response following viral infection. Fig. 1 , antigen-responsive follicular B cells develop GCs and diversify immunoglobulin V genes through somatic hypermutation. 12, 13) The subsequent clonal selection rescues or removes high-or low-affinity variants. Therefore, with the passage of time, high-affinity B cells preferentially accumulate in GCs. 13, 14) Two cellular components within GCs are believed to play crucial roles in the decision as to the survival or death of GC B cells, follicular dendritic cells (FDCs), which display antigens on their processes, and CD4 þ helper T cells. 15) In this model, the competition against antigens on FDCs enables the selection of high-affinity B cells that are capable of receiving survival signals from FDC and T cells through direct interactions. However, a recent imaging study using a two-photon microscope clearly demonstrated that GC B cells interact more frequently with GC T cells than with FDCs, 16) which suggests that helper signals from GC T cells are the limiting factor in the selection of high-affinity B cells. In accordance with this, gene-manipulated mice deficient in antigen complexes on FDC exhibited compatible clonal selection. 17) Moreover, we have found that clonal selection within GC depends on the expression of CD95 and Bcl-xL on B cells, whose functions depend on interaction with helper T cells. 10, 18) Collectively, these data strongly support that helper signals from GC T cells are the limiting factor in the decision as to the survival or death of GC B cells.
Whether developmental pathway, but the role of FDC in these processes remains unclear.
In addition to the canonical GC pathway, memory B cells, but not long-lived plasma cells, appear to be generated through non-GC pathways, which have been undiscovered until recently. It has long been believed that MZ B cells and B1 cells do not differentiate into memory B cells after antigen stimulation, but MZ B cells have been found to participate in the GC reaction in response to T-dependent antigen, and to differentiate into either memory B cells or long-lived plasma cells.
20,21) B1 cells can also generate IgM þ memory B cells in response to T-independent antigen on Borreria.
22) B1-derived IgM þ memory B cells do not participate in the GC reaction. Therefore, they cannot improve their BCR affinity. Since low-affinity memory B cells against T-dependent antigens can be detected in the complete absence of GCs, 23) the GC-independent pathway for memory B cells is not restricted to the Tindependent response. The reason we could not easily detect the GC-independent pathway was possibly that the low-affinity non-GC memory response was masked by the canonical GC memory response comprising highaffinity, isotype-switched antibodies.
24) The phenotypic and functional differences among memory B cells that are generated in GC and non-GC pathways remain to be elucidated.
II. Maintenance and Localization of Memory B Cells and Long-Lived Plasma Cells
Memory B cells and long-lived plasma cells have estimated half-lives of more than 100 d, and these cells sometimes persist in the body for a lifetime. [25] [26] [27] Although CD8 memory T cells require cytokines such as IL-7 and IL-15 for their survival, the survival of memory B cells and long-lived plasma cells does not appear to depend on these cytokines. 28) Memory B cells and long-lived plasma cells appear to utilize different mechanisms for their survival, as evidenced by the differential expression patterns of their surface receptors and homing preferences. Long-lived plasma cells do not express sufficient amounts of BCR on their surfaces. Therefore, as revealed by experiments in which longlived plasma cells were transferred into antigen-free recipient mice, their survival is entirely independent of antigenic stimulation. 24, 29) On the other hand, the role of antigens in the maintenance of memory B cell has long been debated using several experimental systems. 11, 30) Despite the enhanced survival of memory B cells that were stimulated by the antigens on FDC, a study using gene-targeted mice, which conditionally altered antigenrecognition of BCR on memory B cells, suggested that memory B cells can survive for several months without continuous antigen stimulation.
11) But, a question remains whether the persisting memory B cells still retain their general function or homing preference without antigenic stimulation. In fact, CD4 memory T cells can survive for long periods without the persistence of antigen, but their ability to proliferate and secrete cytokines against antigenic re-stimulation is profoundly impaired when they are maintained in the absence of persistent antigen. 31) Although memory B cells and long-lived plasma cells can survive for several months in the complete absence of antigen, this is not sufficient to explain the fact that memory B cells and long-lived plasma cells persist for a lifetime in response to nonreplicating antigens in both humans and mice. In order to be sustained for such a long period, these cells must somehow divide in an antigen-independent manner. Lanzavecchia's group proposed that memory B cells are maintained by homeostatic proliferation mediated through Toll-like receptors (TLRs) and CD40 (Fig. 2) . 32) Supporting this, gene expression profiling has shown that memory B cells share several genes expressed on stem cells.
34)
The precursors for long-lived plasma cells, which are generated either from GC B cells or re-stimulated memory B cells, migrate toward the survival niches in the bone marrow (BM) through the action of CXCL12 chemokine.
35) The migrating plasma cells are continuously stimulated with prosurvival factors such as IL-5, IL-6, ligands for CD44, TNF, CXCL12, and the ligands for B-cell maturation protein (BCMA), which are provided by the surrounding stromal cells. 36, 37) The environment provided by BM stromal cells appears to be optimized not only for the survival of plasma cells, but also for the secretion of antibodies, since antibody secretion of individual plasma cells in BM is increased as compared to those in other organs. 38) III. Accelerated Antibody Production by Memory B Cells The isotype-switched BCR has a C-terminal cytoplasmic domain that is structurally different from that of IgM and IgD, which carry short cytoplasmic domains consisting of only three amino acids. 40) IgG and IgE have long cytoplasmic domains (28 amino acids), and IgA has an intermediate-length cytoplasmic domain (14 amino acids). When the cytoplasmic domain of an IgM BCR was replaced with an IgG tail, antibody production upon stimulation with T cell-dependent antigen was enhanced. 41) This suggests that the signaling pathways mediated by the IgG BCR differ from that of the IgM BCR. In fact, CD22, the inhibitor of BCR signaling, cannot suppress BCR signaling through IgG, but suppresses it through IgM, which suggests that resistance to the inhibitory effect of CD22 is one mechanism that enhances BCR signals. 42) How, then, does enhanced BCR signaling through the IgG-BCR complex promote terminal differentiation of memory B cells?
Recently, we found that BCR signaling via the Ras cascade mediates unique biological processes during the development of memory B cells. 21) In transgenic mice expressing the dominant-negative form of Ha-ras, the memory B cell response was significantly impaired while the primary B cell response to T-dependent antigen was normal. Furthermore, purified memory B cells deficient in Ras signaling did not differentiate into plasma cells in response to antigenic stimulation, but instead died by apoptosis. Hyperactivation by strong BCR signaling induces B-cell apoptosis under certain conditions. Hence memory B cells are likely to adapt to strong BCR signaling that is beneficial for prompt antibody production against a minute amount of reinvading antigen, by suppressing their negative effect through the Ras cascade (Fig. 3) .
IV. Memory B Cell Response to Influenza Virus in the Lower Respiratory Tract
When we think of memory B cell response to live pathogens, we must consider three important factors not present in a hapten-carrier system: (i) live pathogens replicate after invasion; (ii) live pathogens possess complexes of T-dependent and independent antigens, including TLR ligands; and (iii) live pathogens primarily invade through mucosal sites. During an acute infection, the humoral antibody response plays more important roles in the eradication of pathogens than the cellular response. 5) Here, I will discuss memory B-cell responses in a lower respiratory tract acutely infected with an influenza virus, with emphasis on the difference between a systemic and a mucosal humoral response.
As shown in Fig. 4 , influenza viruses infect several types of cells, including dendritic cells, which migrate to the mediastinal lymph nodes (MLNs).
43) The antiinfluenza virus B cell response appears to develop not only in the MLNs, but also in the lungs, since B-cell follicles containing GCs start to develop in the lungs. 44) The anti-influenza virus B-cell response in the lungs involves both IgG and IgA. This is different from the systemic immune response which mainly comprises the IgG response. Curiously, the development of IgA plasma cells can be independent of cognate interaction with helper T cells, whereas IgG response develops in Tdependent manner. 45) The differential requirements of Tcell help in the IgG and IgA responses can be explained by the distinct origins of the cells responsible for these two responses. The T-dependent IgG response can be induced by follicular B cells which are abundantly present in the MLNs and the lungs. B1 cells but not MZ B cells exist in the MLN and the lungs, which accommodate anti-influenza virus antibodies even in the pre-immune repertoire. 46) Moreover, Macpherson et al. have shown that mucosal B1 cells secrete T-independent IgA antibody against intestinal bacteria. 47) This evidence suggests that the T-independent IgA response in the lower respiratory tract is of B1 origin.
Anti-influenza virus IgG and IgA responses are evident in long-lasting serum-antibody titers and the prompt antibody secretion in the nasal wash upon reinfection. 48, 49) Thus IgG þ or IgA þ long-lived plasma cells and quiescent memory B cells appear to develop after an influenza infection. After the initial infection, GCs start to develop both in the MLNs and the lungs, but GCs in the MLNs and lungs are generated and maintained by different kinetics. MLN GCs appear at day 9, reach their peak response approximately by day 14, and then wane by day 40, and thus resembles splenic GCs in the systemic immune response. 50) Although the GC response in the lungs has not been fully examined, GCs are still present even at day 90 postinfection (unpublished results), 51) which suggests that the GC response in the lungs persist for a longer period than that in the MLNs. The persistent GC reaction in the lungs may be due to either continuous recruitment of newly stimulated B cells by a persistent virus or by the increased half-life of GC B cells. The former possibility is supported by the finding that persisting antigen after an influenza infection continuously drives naïve CD8 T cells into cell cycles. 52) To test the latter possibility, we must examine the frequencies of somatic hypermutations, which directly reflect the half-life of GC B cells. Moreover, the physiological roles of persistent GCs in vivo are an important issue that must be elucidated.
Furthermore, we must identify the types of memory B cells that are generated and maintained in the lower respiratory tract. In the case of T cells, memory T cells localized in the peripheral organs (i.e., the lungs and the livers) are called effector memory T cells, whereas those residing in the secondary lymphoid organs are called central memory T cells.
53) The effector memory T cells become localized at pathogen entry sites and rapidly express effector molecules immediately after reinfection, thus accomplishing rapid clearance of the reinfecting pathogens. The central memory T cells maintain the memory pool size by homeostatic proliferation in the secondary lymphoid organs and continuously supply effector memory T cells. Thus quiescent memory B cells fit the criteria of central memory T cells. However, the B-cell counterparts of effector memory T cells have yet to be identified. Lung B cells from mice infected with the influenza virus for more than 20 weeks produced virus-specific antibodies in culture supernatant on stimulation with antigen and T cells in vitro, implying that memory B cells do reside in the lungs. 49) Virusspecific lung B cells must be highly purified to clarify the phenotype and function of these persistent cells. Recently, we successfully purified B cells that are specific to HA of the influenza virus by modifying our previous system for hapten-specific memory B cells (unpublished results). This system allowed us to confirm that HA-specific B cells with the GC phenotype persist for more than 50 d postinfection. Moreover, we also found that HA-specific B cells with memory phenotype and plasma cells persist in the lungs for long periods. Thus the microenvironment in the lungs somehow permits the persistence of three B-cell compartments, GC, memory, and plasma cells, all of which are important to the successful establishment of the humoral memory response. While the molecular basis of their persistence and localization in the lungs remains to be examined, a possible key factor is TLR signals. Among 11 TLRs, the signals through TLR7 possibly controls anti-influenza memory B cell responses, since TLR7 is the receptor for the ssRNA of the influenza virus 54, 55) and is abundantly expressed in memory B cells. 33) Although knockout mice lacking adaptor molecules for all identified TLR signals induced the comparable systemic humoral response, 56) we must carefully examine the effects of TLR signals on the lung memory B cells by conditionally silencing only a limited number of TLR signals in memory B cells. This would avoid the compensatory side effects that might occur due to complete deletion in a wide range of TLR-expressing cells.
V. Concluding Remarks
The robust memory B cell response to reinfecting pathogens is the basis of protective immunity primed by vaccination. In this review, I have discussed the framework of the memory B cell response in systemic immunity, and possible mechanisms underlying the influenza-specific memory B cell response in the lungs. Unfortunately, we have not yet identified many of the cellular compartments and regulatory molecules neces- sary for a full understanding of this response. In this context, our recent development of a cell-sorting strategy for HA-specific B cells in the lungs and further analysis of their phenotypes and functions in vivo should reveal new aspects of memory B-cell responses, which directly correlate with protective immunity. Such information should be useful in the development of new strategies of vaccination not only for the influenza virus but also for many other pathogens acutely infecting the respiratory tract, such as the SARS corona virus and Staphylococcus pneumoniae.
